Company Elite Pharmaceuticals, Inc. Other OTC
Equities
ELTP
US28659T2006
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Abbreviated New Drug Applications
100.0
%
| 32 | 100.0 % | 34 | 100.0 % | +5.87% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 32 | 100.0 % | 34 | 100.0 % | +5.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Douglas Plassche
COO | Chief Operating Officer | 61 | 13-08-11 |
Dianne Will
IRC | Investor Relations Contact | - | 02-12-31 |
Kirko Kirkov
PRN | Corporate Officer/Principal | 56 | 22-09-05 |
George Smith
LAW | General Counsel | - | 14-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,017,881,199 | 791,526,006 ( 77.76 %) | 100,000 ( 0.009824 %) | 77.76 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+19.08% | 44.31B | |
+19.87% | 22.17B | |
+15.08% | 14.62B | |
+9.65% | 13.12B | |
+38.70% | 11.58B | |
-8.96% | 6.96B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.50% | 5.03B |